Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 200 Total
CUTR - Cutera Inc - Stock Price Chart
TickerCUTR [NASD, RUT]
CompanyCutera Inc
CountryUSA
IndustryMedical Devices
Market Cap44.11MEPS (ttm)-7.58
P/E-EPS this Y-3.56%
Forward P/E-EPS next Y38.88%
PEG-EPS past 5Y-27.69%
P/S0.21EPS next 5Y25.00%
P/B-EPS Q/Q-471.58%
Dividend-Sales Q/Q-26.45%
Insider Own5.09%Inst Own87.16%
Insider Trans0.00%Inst Trans-0.93%
Short Float40.89%EarningsMar 21/a
Analyst Recom2.20Target Price6.33
Avg Volume1.18M52W Range1.28 - 24.71
Apr-11-24 08:00AM Cutera Announces the North America Launch of xeo+ (Business Wire) +10.29%
Mar-28-24 01:38PM 15 Best Beauty Stocks To Invest In (Insider Monkey) +5.76%
Mar-22-24 11:40AM Cutera, Inc. (NASDAQ:CUTR) Q4 2023 Earnings Call Transcript (Insider Monkey) -30.43%
07:07AM Q4 2023 Cutera Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-21-24 08:53PM CUTR Stock Earnings: Cutera Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) +9.00%
06:00PM Cutera: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM Cutera Announces Fourth Quarter and Full-Year 2023 Financial Results Along with 2024 Outlook (Business Wire)
Mar-06-24 01:52PM CUTR Stock Earnings: Cutera Misses EPS, Misses Revenue for Q3 2023 (InvestorPlace)
Mar-05-24 07:17PM Cutera: Q3 Earnings Snapshot (Associated Press Finance)
Mar-01-24 08:30AM Cutera to Announce Fourth Quarter and Full-Year 2023 Results on March 21, 2024 (Business Wire) +7.59%
BROG - Brooge Energy Limited - Stock Price Chart
TickerBROG [NASD]
CompanyBrooge Energy Limited
CountryUnited Arab Emirates
IndustryOil & Gas Midstream
Market Cap119.73MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.84EPS Q/Q-25.38%
Dividend-Sales Q/Q-
Insider Own0.00%Inst Own8.77%
Insider Trans-Inst Trans-
Short Float0.01%Earnings-
Analyst Recom1.00Target Price6.40
Avg Volume589.14K52W Range1.07 - 6.66
Apr-04-24 01:07PM Brooge Energy (BROG) and Former Executives Face Additional Potential Liability to Investors for Revenue Inflation and Falsifying Records Hagens Berman (GlobeNewswire)
Mar-30-24 06:01AM Brooge Energy (BROG) and Former Executives Face Additional Potential Liability to Investors for Revenue Inflation and Falsifying Records - Hagens Berman (Newsfile)
Mar-28-24 01:15PM Brooge Energy (BROG) and Former Executives Face Additional Potential Liability to Investors for Revenue Inflation and Falsifying Records Hagens Berman (GlobeNewswire)
Mar-18-24 01:35PM Brooge Energy (BROG) and Former Executives Face Additional Potential Liability to Investors for Revenue Inflation and Falsifying Records Hagens Berman (GlobeNewswire)
Mar-13-24 06:47PM Brooge Energy (BROG) and Former Executives Face Additional Potential Liability to Investors for Revenue Inflation and Falsifying Records Hagens Berman (GlobeNewswire)
11:45AM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Brooge (PR Newswire)
Feb-23-24 01:00PM BROOGE SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Brooge To Contact Him Directly To Discuss Their Options (GlobeNewswire)
11:11AM Brooge Energy (BROG) and Former Executives Face Additional Potential Liability to Investors for Revenue Inflation and Falsifying Records Hagens Berman (GlobeNewswire)
Feb-19-24 12:40PM Investors Sue Brooge Energy (BROG) After SEC Imposes $5 Million Fine For False Invoice Scheme Inflating Revenue Hagens Berman (GlobeNewswire)
Feb-15-24 02:01PM Investors Sue Brooge Energy (BROG) After SEC Imposes $5 Million Fine For False Invoice Scheme Inflating Revenue Hagens Berman (GlobeNewswire)
GBR - New Concept Energy Inc - Stock Price Chart
TickerGBR [AMEX]
CompanyNew Concept Energy Inc
CountryUSA
IndustryReal Estate Services
Market Cap6.16MEPS (ttm)-0.00
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y54.28%
P/S41.04EPS next 5Y-
P/B1.35EPS Q/Q-461.90%
Dividend-Sales Q/Q-35.09%
Insider Own27.18%Inst Own2.12%
Insider Trans0.00%Inst Trans-28.28%
Short Float0.67%Earnings-
Analyst Recom-Target Price-
Avg Volume15.66K52W Range0.91 - 1.40
ENLV - Enlivex Therapeutics Ltd - Stock Price Chart
TickerENLV [NASD]
CompanyEnlivex Therapeutics Ltd
CountryIsrael
IndustryBiotechnology
Market Cap29.37MEPS (ttm)-1.56
P/E-EPS this Y44.87%
Forward P/E-EPS next Y36.05%
PEG-EPS past 5Y32.51%
P/S-EPS next 5Y-
P/B0.98EPS Q/Q-25.32%
Dividend-Sales Q/Q-
Insider Own19.44%Inst Own1.64%
Insider Trans0.00%Inst Trans-13.30%
Short Float1.58%Earnings-
Analyst Recom1.00Target Price7.00
Avg Volume131.78K52W Range1.20 - 4.59
Apr-11-24 02:58PM Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra In Patients with Sepsis (GlobeNewswire) -54.02%
08:05AM Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis (GlobeNewswire)
Apr-05-24 07:52AM ENLV Stock Earnings: Enlivex Therapeutics Misses EPS for Q4 2023 (InvestorPlace) +6.38%
Mar-22-24 10:50AM Enlivex Therapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV (ACCESSWIRE)
Feb-26-24 08:30AM Enlivex Receives Regulatory Authorization From Israel's Health Ministry For The Initiation Of Phase 1/2 Trial Evaluating Allocetra In Patients With Knee Osteoarthritis (ACCESSWIRE)
Feb-21-24 08:30AM Enlivex Completes Enrollment Of All 120 Patients In Phase 2 Trial Of Allocetra In Patients With Sepsis, Third-Leading Cause Of Mortality In US Hospitals (ACCESSWIRE)
Feb-07-24 08:00AM Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method (GlobeNewswire)
Jan-17-24 08:00AM Enlivex Receives IMOH Regulatory Authorization for the Initiation of a Multi-Country, Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Up To 160 Patients with Moderate to Severe Knee Osteoarthritis (GlobeNewswire)
Dec-20-23 08:00AM Enlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis (GlobeNewswire) +22.96%
Nov-21-23 07:00AM MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer (GlobeNewswire)
SLNH - Soluna Holdings Inc - Stock Price Chart
TickerSLNH [NASD]
CompanySoluna Holdings Inc
CountryUSA
IndustryCapital Markets
Market Cap4.60MEPS (ttm)-23.48
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.22EPS next 5Y-
P/B0.15EPS Q/Q93.58%
Dividend-Sales Q/Q141.88%
Insider Own17.52%Inst Own7.51%
Insider Trans0.73%Inst Trans12.75%
Short Float4.74%Earnings-
Analyst Recom-Target Price-
Avg Volume97.84K52W Range2.09 - 9.75
RLYB - Rallybio Corp - Stock Price Chart
TickerRLYB [NASD, RUT]
CompanyRallybio Corp
CountryUSA
IndustryBiotechnology
Market Cap83.18MEPS (ttm)-1.84
P/E-EPS this Y15.53%
Forward P/E-EPS next Y8.18%
PEG-EPS past 5Y-35.52%
P/S-EPS next 5Y-
P/B0.78EPS Q/Q-9.18%
Dividend-Sales Q/Q-
Insider Own54.41%Inst Own35.79%
Insider Trans0.00%Inst Trans0.49%
Short Float7.60%EarningsMar 12/b
Analyst Recom1.00Target Price12.60
Avg Volume1.53M52W Range1.23 - 9.14
OCX - Oncocyte Corporation - Stock Price Chart
TickerOCX [NASD]
CompanyOncocyte Corporation
CountryUSA
IndustryDiagnostics & Research
Market Cap22.38MEPS (ttm)-23.85
P/E-EPS this Y1.22%
Forward P/E-EPS next Y-
PEG-EPS past 5Y14.72%
P/S14.92EPS next 5Y-
P/B1.09EPS Q/Q-28.57%
Dividend-Sales Q/Q-69.12%
Insider Own8.01%Inst Own54.92%
Insider Trans0.00%Inst Trans-33.80%
Short Float2.36%EarningsApr 12/b
Analyst Recom1.00Target Price3.60
Avg Volume14.63K52W Range2.08 - 7.00
AWIN - AERWINS Technologies Inc - Stock Price Chart
TickerAWIN [NASD]
CompanyAERWINS Technologies Inc
CountryUSA
IndustryScientific & Technical Instruments
Market Cap2.16MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-99.99%
Dividend-Sales Q/Q-
Insider Own32.61%Inst Own2.69%
Insider Trans0.00%Inst Trans-
Short Float0.89%Earnings-
Analyst Recom1.00Target Price100.00
Avg Volume20.36K52W Range4.21 - 105.99
MOLN - Molecular Partners AG ADR - Stock Price Chart
TickerMOLN [NASD]
CompanyMolecular Partners AG ADR
CountrySwitzerland
IndustryBiotechnology
Market Cap129.76MEPS (ttm)-2.11
P/E-EPS this Y-17.28%
Forward P/E-EPS next Y3.63%
PEG-EPS past 5Y-3.32%
P/S16.64EPS next 5Y-
P/B0.62EPS Q/Q-35.29%
Dividend-Sales Q/Q-58.41%
Insider Own-Inst Own2.91%
Insider Trans-Inst Trans-1.05%
Short Float-EarningsMar 14/a
Analyst Recom3.00Target Price8.50
Avg Volume3.67K52W Range3.35 - 7.32
Mar-26-24 09:26AM Molecular Partners Publishes Invitation to Annual General Meeting 2024 (GlobeNewswire)
Mar-14-24 04:00PM Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023 (GlobeNewswire)
Mar-01-24 04:00PM Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations (GlobeNewswire)
Jan-07-24 04:00PM Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-05-24 04:00PM Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies (GlobeNewswire)
Dec-14-23 01:00AM Molecular Partners to Present at 42nd Annual J.P. Morgan Healthcare Conference and Swiss Investor Conferences (GlobeNewswire) +7.41%
Dec-10-23 12:00PM Molecular Partners Presents Positive Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at ASH Annual Meeting (GlobeNewswire)
Nov-14-23 01:00AM Molecular Partners to Present on DARPin Oncology Innovations at Protein & Antibody Engineering Summit Europe (PEGS) (GlobeNewswire)
Nov-03-23 12:00PM Molecular Partners Presents Updated Positive Data from Ongoing Phase 1 Trial of MP0317 (FAP X CD40) Monotherapy in Patients with Advanced Solid Tumors at the 2023 SITC Annual Meeting (GlobeNewswire) +10.53%
Nov-02-23 02:00AM Molecular Partners to Present Initial Data from Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at the 65th ASH Annual Meeting and Exposition (GlobeNewswire) +14.52%
BSGM - Biosig Technologies Inc - Stock Price Chart
TickerBSGM [NASD]
CompanyBiosig Technologies Inc
CountryUSA
IndustryMedical Devices
Market Cap12.69MEPS (ttm)-4.76
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y12.54%
P/S90.63EPS next 5Y-
P/B-EPS Q/Q57.30%
Dividend-Sales Q/Q-99.26%
Insider Own17.06%Inst Own11.37%
Insider Trans0.00%Inst Trans4.59%
Short Float8.98%Earnings-
Analyst Recom1.00Target Price50.00
Avg Volume1.05M52W Range0.26 - 16.50
12345671020